Merck (NYSE:MRK) announced European Commission approval of KEYTRUDA plus Padcev for adults with resectable muscle-invasive bladder cancer, regardless of eligibility for cisplatin-based chemotherapy.
BankUnited (NYSE:BKU) reported third-quarter 2026 net income of $72.2 million, compared with $70.7 million sequentially and $71.9 million a year earlier.
APEX Tech Acquisition (NYSE:TRAD) reportedly agreed to merge with entertainment platform Korai Flix at a pre-money equity valuation of $3.5 billion.
Wabtec Corporation (NYSE:WAB) reported third-quarter 2026 sales of $3.12 billion, up 8.1% year over year, driven by growth across its Freight and Transit businesses.
AT&T (NYSE:T) reported third-quarter 2026 revenue of $32.3 billion, up 5.3% year over year, supported by growth in its advanced connectivity businesses.
Integra LifeSciences (NASDAQ:IART) reported third-quarter 2026 revenue of $411.2 million, up 2.3% year over year despite supply disruptions at its Cincinnati manufacturing facility.
Elevance Health (NYSE:ELV) reported third-quarter 2026 operating revenue of $50.4 billion, up 0.7% year over year, supported by its diversified healthcare businesses.
Thermo Fisher Scientific (NYSE:TMO) reported third-quarter 2026 revenue of $12.14 billion, up 9% year over year, supported by growth across its scientific products and services businesses.
Danaher (NYSE:DHR) reported third-quarter 2026 revenue of $6.554 billion, up 8.5% year over year, supported by growth across its life sciences and diagnostics operations.
SCHMID Group (NASDAQ:SHMD) raised its full-year 2026 order intake guidance to more than €150 million following stronger equipment demand during the third quarter.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
